FIND urine sample purification and D-arabinose analysis.

<p>IS = Internal Standard; HIV = Human Immunodeficiency Virus; Pneu = Pneumonia; Atyp = Atypical TB,</p

Protocol for derivatization of D-Arabinose in urinary LAM and the corresponding mass fragmentation pattern.

<p>Protocol for derivatization of D-Arabinose in urinary LAM and the corresponding mass fragmentation pattern.</p

Differences in peak patterns and retention times in GC/MS chromatogram for D- and L- arabinose.

<p>Differences in peak patterns and retention times in GC/MS chromatogram for D- and L- arabinose.</p

Representative schematic structure of ManLAM, Insert in the Blue box show residues adapted as strategic surrogates for LAM.

<p>Representative schematic structure of ManLAM, Insert in the Blue box show residues adapted as strategic surrogates for LAM.</p

Summary of results for the GC/MS based urinary LAM detection on clinical samples.

<p>Summary of results for the GC/MS based urinary LAM detection on clinical samples.</p

Protocol for TBSA detection by GC/MS.

<p>Protocol for TBSA detection by GC/MS.</p

TBSA Based LAM Estimation of 29 Urine Samples (TBSSMC -, D-Arabinose/LAM positive).

<p>TBSA Based LAM Estimation of 29 Urine Samples (TBSSMC -, D-Arabinose/LAM positive).</p

D-Arabinose estimation of Non-Endemic-Urine (NEU).

<p>1) Internal standard, 2) D-arabinose in NEU before purification; 3) D-arabinose not detected in NEU after purification.</p

Performance of three LED-based fluorescence microscopy devices in detection of tuberculosis in HIV-positive suspects in Kampala, Uganda, per specimen analysis.

*<p>For sensitivity calculations, the denominator is the number of specimens for which the culture was positive for MTB. For specificity, the denominator shows the number of culture negative specimens.</p

False positive results.

<p>False positive results.</p